Page last updated: 2024-11-03

risperidone and Cirrhosis, Liver

risperidone has been researched along with Cirrhosis, Liver in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heykants, J2
Huang, ML1
Mannens, G2
Meuldermans, W1
Snoeck, E2
Van Beijsterveldt, L1
Van Peer, A2
Woestenborghs, R2
Sack, M1
Horton, M1
Meibach, R1

Trials

1 trial available for risperidone and Cirrhosis, Liver

ArticleYear
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.
    Psychopharmacology, 1995, Volume: 122, Issue:3

    Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Blood Proteins; Female; Half-Life; Humans; Kidney Fa

1995

Other Studies

1 other study available for risperidone and Cirrhosis, Liver

ArticleYear
The pharmacokinetics of risperidone in humans: a summary.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Aged; Animals; Antipsychotic Agents; Biotransformation; Dogs; Half-Life; Humans; Isoxazoles; Liver C

1994